We are live on ! Find out more
MD icon

Pediatrix Medical

227 hedge funds and large institutions have $659M invested in Pediatrix Medical in 2024 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 73 increasing their positions, 80 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

237% more call options, than puts

Call options by funds: $165K | Put options by funds: $49K

48% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 33

7% more funds holding

Funds holding: 213227 (+14)

2.63% more ownership

Funds ownership: 101.12%103.74% (+2.6%)

9% less repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 80

23% less capital invested

Capital invested by funds: $853M → $659M (-$194M)

Holders
227
Holders Change
+14
Holders Change %
+6.57%
% of All Funds
3.28%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
49
Increased
73
Reduced
80
Closed
33
Calls
$165K
Puts
$49K
Net Calls
+$116K
Net Calls Change
-$287K

MD Hedge Fund Activity: Q2 2024 in Review

227 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q2 2024, worth a combined $659M — down 23% from $853M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new MD positions and 33 closed out — a net gain of 16 holders — while 73 added to existing stakes and 80 trimmed.

The largest buyer was Rubric Capital Management (New York), adding an estimated $59.9M. The largest seller was Pacer Advisors, exiting entirely with an estimated $52.4M sold.

  • 227 institutional investors held Pediatrix Medical (MD) as of Q2 2024, up from 213 in Q1 2024.
  • Funds reported $659M of Pediatrix Medical stock for Q2 2024, down 23% quarter-over-quarter.
  • 49 funds opened new Pediatrix Medical positions in Q2 2024 and 33 closed out, a net change of +16 holders.
  • The largest Pediatrix Medical buyer in Q2 2024 was Rubric Capital Management (New York), an estimated $59.9M added.
  • The largest Pediatrix Medical seller in Q2 2024 was Pacer Advisors, an estimated $52.4M sold.

Based on aggregated 13F filings for Q2 2024.